NCT01934803View on ClinicalTrials.gov

Zinc for HIV Disease Among Alcohol Users - an RCT in the Russia ARCH Cohort

NACompletedINTERVENTIONAL
Enrollment

254

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

February 28, 2017

Study Completion Date

November 8, 2018

Conditions
HIV InfectionAlcohol Use
Interventions
DIETARY_SUPPLEMENT

Zinc gluconate

Study participants will be randomly assigned to a zinc gluconate or placebo group and will be instructed to take one pill of study medication orally daily for 18 months.

DIETARY_SUPPLEMENT

Placebo

Trial Locations (1)

Unknown

Pavlov State Medical University, Saint Peterburg

Sponsors
All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Boston Medical Center

OTHER